From all of us at Pharming, wishing you a Happy New Year and a great start to 2025!
Pharming Group N.V.
Biotechnologisch onderzoek
Transforming the future for our patients.
Over ons
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com.
- Website
-
http://www.pharming.com
Externe link voor Pharming Group N.V.
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 201 - 500 medewerkers
- Hoofdkantoor
- Leiden
- Type
- Naamloze vennootschap
- Opgericht
- 1988
- Specialismen
- Bio Technology en Pharmaceutical
Locaties
-
Primair
Routebeschrijving
Darwinweg 24
Leiden, 2333 CR, NL
-
Routebeschrijving
Medewerkers van Pharming Group N.V.
Updates
-
The Pharming Group N.V. management team will be in San Francisco in January. To schedule a meeting please register here: https://bit.ly/3Vm9YOT or contact investor@pharming.com or bd@pharming.com #JPM2025
-
-
For investors and media: Pharming Group N.V. announces public cash offer to the shareholders of Abliva AB. To read the full press release, click here: https://bit.ly/3OWOqEL Abliva shareholders should refer to the formal announcement published in Swedish and English by Pharming: www.raredisease-offer.com
-
-
For investors and medical media: We are pleased to announce positive topline data in the Phase III pediatric clinical trial evaluating tablets of our PI3K delta inhibitor for children 4 to 11 years of age who have APDS, a rare and progressive genetic immunodeficiency. To read the full press release, click here: https://bit.ly/4g4GRYw
-
-
Pharming Group N.V. is pleased to welcome Inés Bernal as our new Chief People Officer (CPO) and member of the Executive Committee as of December 1, 2024. For more information, please visit our website: https://bit.ly/3ViYqeW
-
-
Tomorrow our CEO, Sijmen De Vries, will present at the Jefferies London Healthcare Conference at 08:00 GMT/09:00 CET. Watch the live webcast here: https://bit.ly/3CoueIW #JefferiesHealthcare #conferences2024 #biopharma #pharminggroup
-
-
We are happy to share that Pharming Group N.V. management will participate in the Jefferies London Healthcare Conference in the month of November. https://bit.ly/3UCDzTO To schedule a meeting with management, please reach out to investor@pharming.com. #JefferiesHealthcare #conference2024 #biopharma #pharminggroup
-
-
This morning Pharming Group N.V. published its third quarter 2024 financial results. To read the press release please click here: https://bit.ly/40ixgZg As a reminder, management will hold an analyst and investor call today October 24 at 13:30 CEST/07:30 EDT to discuss the third quarter of 2024. Information for the call can be found in the press release. #3Q24 #9M24 #financialresults #pharminggroup
-